el documento - Biblioteca Digital FCEN UBA - Universidad de ...

[309] Fraser HM, Bramley TA, Miller WR, Sharpe RM. Extra pituitary actions of LHRH analogues
in tissues of the human female and investigation of the existence and function of LHRH-like
peptides. Prog. Clin. Biol. Res. 1986; 225: 29-54.
[310] Guerrero HE, Stein P, Asch RH, de Fried EP, Tesone M. Effect of a gonadotropin-releasing
hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil.
Steril. 1993; 59: 803-808.
[311] Srivastava RK, Sridaran R. Inhibition of luteal steroidogenesis by two LHRH antagonists
(Nal-Glu and Nal-Arg antagonists) in the pregnant rat. Endocr. Res. 1994; 20: 365-376.
[312] Knetch M, Amsterdam A, Catt KJ. Inhibition of granulosa cell differentiation by
gonadotropin-releasing hormone. Endocrinology 1982; 110: 865-872.
[313] Andreu C, Parborell F, Vanzulli S, Chemes H, Tesone M. Regulation of follicular luteinization
by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and
apoptosis. Mol. Reprod. Dev. 1998; 51: 287-294.
[314] Sridaran R, Philip GH, Li H, Culty M, Liu Z, Stocco DM, Papadopoulos V. GnRH agonist
treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA,
ligand binding and steroidogenic acute regulatory protein expression during pregnancy. J.
Mol. Endocrinol. 1999; 22: 45-54.
[315] Parborell F, Dain L, Tesone M. Gonadotropin-releasing hormone agonist affects rat ovarian
follicle development by interfering with FSH and growth factors on the prevention of
apoptosis. Mol. Reprod. Dev. 2001; 60: 241-247.
[316] Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic
cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487.
[317] Saito M, Korsmeyer SJ, Schlesinger PH. BAX-dependent transport of cytochrome c
reconstituted in pure liposomes. Nat. Cell Biol. 2000; 2: 553-555.
[318] Wilson AC, Meethal SV, Bowen RL, Atwood CS. Leuprolide acetate: a drug of diverse
clinical applications. Expert. Opin. Investig. Drugs 2007; 16: 1851-1863.
[319] McGee E, Spears N, Minami S, Hsu SY, Chun SY, Billig H, Hsueh AJ. Preantral ovarian
follicles in serum-free culture: suppression of apoptosis after activation of the cyclic guanosine
3',5'-monophosphate pathway and stimulation of growth and differentiation by folliclestimulating
hormone. Endocrinology 1997; 138: 2417-2424.
[320] Young KA, Hennebold JD, Stouffer RL. Dynamic expression of mRNAs and proteins for
matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the
menstrual cycle. Mol. Hum. Reprod. 2002; 8: 833-840.
[321] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of
protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
[322] Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP. Inhibin and activin locally regulate
rat ovarian folliculogenesis. Endocrinology 1990; 127: 3196-3205.
[323] Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a
review of structure/function relationships. Endocr. Rev. 1985; 6: 371-399.
[324] Yano T, Yano N, Matsumi H, Morita Y, Tsutsumi O, Schally AV, Taketani Y. Effect of
luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development. Horm.
Res. 1997; 48 Suppl 3: 35-41.
177